Learn more about our Ethylene Oxide & Sterilization work.
AdvaMed, The Medtech Association®, urges the Environmental Protection Agency (EPA) to heed concerns of medtech supply shortfalls under its proposed requirements on ethylene oxide (EtO) sterilization and consider the effects…
AdvaMed®: “We place the highest priority on the safety of our communities, employees, and the millions of patients we serve.” WASHINGTON, D.C. – This week, medtech leaders from across the country…
AdvaMed, The Medtech Association®, today called upon the U.S. Environmental Protection Agency (EPA) to double the time it will allow for public comment on two proposed updates to regulations governing…
The Environmental Protection Agency (EPA) today released its proposed rule regulating ethylene oxide (EtO) sterilizers of medical technology and other commercial uses through the National Emission Standards for Hazardous Air…
Each year in the U.S., ethylene oxide sterilizes 20 billion medical devices, which are critical to preventing serious, even life-threatening, infections.
A lack of public information persists about sterilizing medical devices with ethylene oxide gas. That’s why Scott Whitaker talked with Dr. Lucy Fraiser, a board-certified toxicologist, about the facts.
In a letter to the White House, the Advanced Medical Technology Association® (AdvaMed®) outlined four key priorities in pending regulations for facilities sterilizing medical devices with ethylene oxide (EtO).
AdvaMed®’s Scott Whitaker sits down on the latest episode of the Medtech POV podcast with toxicologist Dr. Lucy Fraiser to discuss the recent news about ethylene oxide (EtO) used to…
Lucy Fraiser, Ph.D., a board-certified toxicologist, recently responded in a letter to the editor of Modern Healthcare about the publication’s recent coverage of the EPA’s work on ethylene oxide.
Scott Whitaker, President and CEO of AdvaMed®, made a statement on EPA’s naming of 23 commercial sterilization facilities as the subject of community meetings over possible health risks.